Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FJH2R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,580
Award facts
- Contract value 100% obligated
- $34,579.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,579.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 150 mg/mL SKYRIZI (risankizumab), a biologic immunosuppressant medication used to treat inflammatory conditions. This non-set-aside contract was awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving the federal healthcare supply chain, particularly military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the contractor to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical's pharmaceutical procurement strategy demonstrates the critical role commercial pharmaceutical distributors play in sustaining federal medical supply chains across the Department of Defense and related healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FJH2R?
SPE2DR26FJH2R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FJH2R worth?
The government has obligated $34,580 on SPE2DR26FJH2R.
Is contract SPE2DR26FJH2R an order under another contract?
Yes. SPE2DR26FJH2R is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH2R competed?
The extent of competition for SPE2DR26FJH2R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award